Marc A. Silver, MD, FACP, FACC, FCCP, FAHA, FHFSA

Dr. Marc A. Silver served as the Chief, Division of Medical Services, Chairman of the Department of Medicine, and was the Founder of the Heart Failure Institute at Advocate Christ Medical Center in Oak Lawn, Illinois from 1998 to 2018. He is an international leader in heart failure, a founding member of the Heart Failure Society of America, author of HFSA and ACC/AHA heart failure guidelines for over a decade, and served as Editor-in-Chief of Congestive Heart Failure for 15 years. 

Throughout his career, his focus has been to optimize care and outcomes for patients, families, provider teams, and health systems.


Teri Patterson, RN, CHFN, CVRN-BC

Teri Patterson has 29 years of cardiac experience and is as a certified heart failure nurse. As an HF coordinator, she has led quality initiatives to significantly reduce HF readmissions and worked with clinicians in utilizing the BVA test to improve patient outcomes. She has served as a speaker at numerous conferences including the AHA/ASA 2017 Mid-Atlantic Heart and Stroke Quality Summit–Heart Failure Conference. 

Her long-standing commitment is to improve the quality of life for heart failure patients.


Cynthia A. Stavish, MSN, APRN, ACNS-BC, PHN

Cynthia A. Stavish has 30 years of critical care nursing experience including trauma ICU, cardiovascular ICU, solid organ transplant, medical ICU, surgical ICU, and emergency nursing. She is an expert in the care of the complicated critically ill patient, acute decompensated heart failure, pain and sedation management in the mechanically ventilated patient, delirium identification and clinical management, cardiac, lung, and liver transplant, ARDS, and septic shock. She has co-authored numerous research articles and has written and presented numerous educational programs. 

Throughout her career, Cynthia has focused on evidence-based care and improved quality of life following critical illness.

What is the BVA-100 Test?

The BVA-100 is an FDA-cleared diagnostic test approved to:

  • Measure intravascular total blood volume, red blood cell volume and plasma volume
  • Calculate patient-specific ideal volumes based on height, weight and gender
  • Quantify the percent deviation from the predicted ideal normal value in milliliters and as a percentage  expressing whether the patient has normal, expanded or depleted volumes
  • Report the albumin transudation rate as an indicator of capillary permeability

Dozens of published peer-reviewed studies across many medical conditions have proven the BVA-100’s unique safety, accuracy, efficacy, and value. Accurate quantification of total blood volume, plasma volume, and red blood cell volume analysis informs physicians leading to better treatment strategies and better patient outcomes.

Partner With the Dedicated Leader in BVA

As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.

Volume is Vital. End the Debate With Daxor.

Call us at 865-425-0555.

 

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.

Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 865-425-0555 | Fax: 516-828-4772
info@daxor.com | daxor.com

ISO 13485 Certified

Made in the USA.

COPYRIGHT 2021 © DAXOR CORPORATION – ALL RIGHTS RESERVED.